Form 4 holding
Director
RVL Pharmaceuticals plc
- Security class
- Ordinary Shares
- Shares / value
- 40,000
- Estimated value
- $1,248
- Report date
- 05 Jul 2023
- Price
- $0.0312
- Ownership
- Direct
Michael J. DeBiasi
Insider Reports History
- Reporting-owner location
- Bridgewater, NJ
- Latest reporting-owner signature
-
/s/ Brian Markison, as attorney-in-fact
Source: Latest parsed Forms 3/4/5 signature
- Transaction source note
- Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.
Identity
Names, identifiers, and filing context for this profile.
1 identity field
SEC source record
Original filing metadata and source links for verification.
1 source field
Source evidence
Original filing metadata and source links for verification.
1 source field
Reported holdings for Michael J. DeBiasi
Insider Reports Filed by Michael J. DeBiasi
4
RVL Pharmaceuticals plc
- Report period
- 05 Jul 2023
- Transactions
- 1
- Transaction value
- $0
- Accepted by SEC
- 11 Jul 2023, 21:17
- Role
- Director
- Next action
- Open filing details